Predict your next investment

Venture Capital
remind.vc

See what CB Insights has to offer

Investments

11

About re.Mind Capital

re.Mind Capital is the mental health VC arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group.

re.Mind Capital Headquarter Location

Block A, Apt. 12, Il-Piazzetta, Tower Road

Sliema, 1605,

Malta

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest re.Mind Capital News

iLoF secures funds to accelerate personalised patient care tech

Aug 1, 2022

UKHotViews Biotech startup iLoF (intelligent Lab on Fiber), has secured c.$5m (£4.1m) to help develop its intelligent drug development platform. The funding includes $4m in equity investment led by Faber, with additional participation from M12 (formerly Microsoft Ventures), Quiet Capital, Lunar Ventures, Alter Venture Partners, re.Mind Capital, Fluxunit, and angel investors. The company also secured an €880k grant from the European Regional Development Fund. The latest investment takes total funding to date to over $8m. The company, which has offices in Oxford, London, Porto and Lisbon, was founded by Luis Valente (CEO), Mehak Mumtaz (COO), and Paula Sampaio (CSO) in 2019. It was initially formed while participating in the EIT Health Wild Card programme; was part of the third cohort of companies supported by Oxford Foundry's Elevate programme ; and was one of thirteen companies chosen by Microsoft to join its AI for Social Impact programme last year. The company is using AI and photonics to create bio-digital twins of biological profiles and disease subtypes, which are stored in its cloud-based library with the aim of making clinical trials faster, cheaper and more patient-centric. It uses optical lasers to analyse blood samples, acquiring signals that can be processed using its AI technology to create a unique digital molecular profile that can be compared with other digital fingerprints. This information can then be used to develop personalised treatments. To date, the key focus for the technology has been in delivering a non-invasive way of stratifying patients for Alzheimer’s disease clinical trials, but it has also been used for forecasting COVID-19 disease severity, and for cancer subtype identification. The seed investment will be used by iLoF to help scale its operations, including hiring 20 new employees across the fields of physics, data science, biology, and product management. It intends to build on its existing partnerships with pharmaceutical, biotech, and clinical organisations with the aim of accelerating pilot studies. It will also invest in further development of the iLoF Platform as it seeks to position itself at the forefront of the new era of AI-enabled personalised patient care.

re.Mind Capital Investments

11 Investments

re.Mind Capital has made 11 investments. Their latest investment was in iLoF as part of their Seed VC - II on July 7, 2022.

CBI Logo

re.Mind Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/28/2022

Seed VC - II

iLoF

$4.06M

Yes

3

3/8/2022

Series A

OccamzRazor

$6.1M

Yes

2

1/12/2022

Series B

Ceregate

Yes

1

12/15/2021

Unattributed VC

Subscribe to see more

Subscribe to see more

10

10/12/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/28/2022

3/8/2022

1/12/2022

12/15/2021

10/12/2021

Round

Seed VC - II

Series A

Series B

Unattributed VC

Seed VC - II

Company

iLoF

OccamzRazor

Ceregate

Subscribe to see more

Subscribe to see more

Amount

$4.06M

$6.1M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

2

1

10

10

re.Mind Capital Team

1 Team Member

re.Mind Capital has 1 team member, including current Founding Partner, Jan Hardorp.

Name

Work History

Title

Status

Jan Hardorp

Waterland Private Equity Investments, Stroer, McKinsey & Company, Merrill, and Bundeswehr

Founding Partner

Current

Name

Jan Hardorp

Work History

Waterland Private Equity Investments, Stroer, McKinsey & Company, Merrill, and Bundeswehr

Title

Founding Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.